When conducting clinical trials of a new drug, the goal is to get a clear understanding of the effectiveness and potential hazards of the new drug before marketing and selling it. By varying the doses given to the clinical trial participants, companies can determine the safety and effectiveness of different amounts of the drug. They can evaluate how much of the drug is necessary to be effective, the side effects that may occur with different dosages, and whether the intensity of side effects changes at different dosages. Companies can also compare the effectiveness and side effects of their drugs against other similar drugs used to treat the same disease.
I really don't know, why would you want to know though? I would suspect low doses over a long period of time or high doses at varying amount if time.
I believe they should, so that medication doses can be adjusted for renal impairment.
Physicians prescribe the medication in varying total daily dosages. Typically, the total daily dosage is administered in three to four divided doses.
Melatonin is available over the counter in varying doses of up to 3 mg per tablet. However, a fraction of this is required for insomnia, usually about 0.3 mg or less.
Yes and No. Writing up charts with doses of meds requires writing. I takes some math for obvious reasons.
"Doses collaborated" likely refers to the combined efforts or contributions of different doses of a medication or treatment in a clinical or therapeutic context. This could involve studying how varying dosages interact or work together to achieve a desired effect or outcome. In research, it might also pertain to collaborative studies that assess the efficacy and safety of different dosages in a population. However, without more context, the exact meaning may vary.
No. Acetaminophen is the ingredient in Tylenol. "Speed" is a broad term used to describe "uppers", which usually consists of high doses of caffeine, ephedrine or amphetamines.
Adults An initial dose of 50 mg every 4 weeks is recommended, increasing if necessary by 50 mg increments up to 200 mg every 4 weeks. Subsequent monthly doses should be assessed on the individual patient's response. If, for clinical reasons, two-weekly administration is preferred these doses should be halved. In patients with severe symptomatology, or in those who require large oral doses for maintenance, higher doses may be required
Three doses
Little Doses was created in 2006.
The idea of 'law of similars' had first been mentioned by Hippocrates, then by Paracelsus, and later by others. The law states that disease in sick people can be cured by a medicine given in micro doses that produces similar symptoms in health people when given in large doses.
When studying the effect (efficacy) of a medication, researchers will give some subjects doses of the medication under study and others an inactive or inert doses to see the relative effect of the medication. This known as a 'blind study' because the participants do not know know whether they received the medication or the inert dose. A 'double blind study' is when a third party designs the experiment and prepares the doses so that neither the subject or the scientist doing the testing knows which is getting the live dose.